Kamyar MR - Search Results

1

Evaluation of educational needs in patients with diabetes mellitus in respect of medication use in Austria.

Lemmens-Gruber R, Hahnenkamp C, Gössmann U, Harreiter J, Kamyar MR, Johnson BJ, Hudson S, Kautzky-Willer A. Lemmens-Gruber R, et al. Among authors: kamyar mr. Int J Clin Pharm. 2012 Jun;34(3):490-500. doi: 10.1007/s11096-012-9636-0. Epub 2012 Apr 24. Int J Clin Pharm. 2012. PMID: 22527481

2

Adherence to clinical guidelines in the prevention of coronary heart disease in type II diabetes mellitus.

Kamyar M, Johnson BJ, McAnaw JJ, Lemmens-Gruber R, Hudson SA. Kamyar M, et al. Pharm World Sci. 2008 Jan;30(1):120-7. doi: 10.1007/s11096-007-9154-7. Epub 2007 Aug 25. Pharm World Sci. 2008. PMID: 17721698

3

Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus.

Kautzky-Willer A, Kamyar MR, Gerhat D, Handisurya A, Stemer G, Hudson S, Luger A, Lemmens-Gruber R. Kautzky-Willer A, et al. Among authors: kamyar mr. Gend Med. 2010 Dec;7(6):571-83. doi: 10.1016/j.genm.2010.12.001. Gend Med. 2010. PMID: 21195357

4

Clinical characteristics, modalities and complications of diabetic patients with migration background at a Central European University Clinic.

Handisurya A, Bancher-Todesca D, Kamyar MR, Lemmens-Gruber R, Kautzky-Willer A. Handisurya A, et al. Among authors: kamyar mr. Wien Med Wochenschr. 2011 Mar;161(5-6):128-35. doi: 10.1007/s10354-011-0870-1. Epub 2011 Mar 7. Wien Med Wochenschr. 2011. PMID: 21360290

5

Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study.

Kautzky-Willer A, Stich K, Hintersteiner J, Kautzky A, Kamyar MR, Saukel J, Johnson J, Lemmens-Gruber R. Kautzky-Willer A, et al. Among authors: kamyar mr. Cardiovasc Diabetol. 2013 May 24;12:78. doi: 10.1186/1475-2840-12-78. Cardiovasc Diabetol. 2013. PMID: 23705959 Free PMC article.

6

Vasopressin antagonists.

Lemmens-Gruber R, Kamyar M. Lemmens-Gruber R, et al. Cell Mol Life Sci. 2006 Aug;63(15):1766-79. doi: 10.1007/s00018-006-6054-2. Cell Mol Life Sci. 2006. PMID: 16794787 Free PMC article. Review.

7

[Pharmacology and clinical relevance of vasopressin antagonists].

Lemmens-Gruber R, Kamyar M. Lemmens-Gruber R, et al. Internist (Berl). 2008 May;49(5):628, 629-30, 632-4. doi: 10.1007/s00108-008-2017-z. Internist (Berl). 2008. PMID: 18335184 Review. German.

8

Cyclodepsipeptides - potential drugs and lead compounds in the drug development process.

Lemmens-Gruber R, Kamyar MR, Dornetshuber R. Lemmens-Gruber R, et al. Among authors: kamyar mr. Curr Med Chem. 2009;16(9):1122-37. doi: 10.2174/092986709787581761. Curr Med Chem. 2009. PMID: 19275616 Review.

9

Actions of the antibiotic mycotoxins beauvericin and enniatin on mammalian tissue.

Kouri K, Kamyar MR, Lemmens-Gruber R. Kouri K, et al. Among authors: kamyar mr. Forum Nutr. 2003;56:413-4. Forum Nutr. 2003. PMID: 15806956 No abstract available.

10

Investigation of the electrophysiological properties of enniatins.

Kamyar M, Rawnduzi P, Studenik CR, Kouri K, Lemmens-Gruber R. Kamyar M, et al. Arch Biochem Biophys. 2004 Sep 15;429(2):215-23. doi: 10.1016/j.abb.2004.06.013. Arch Biochem Biophys. 2004. PMID: 15313225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters